Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion — Stella

Recruiting

Back to Radial Artery Occlusion trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(3 sites)

United States

Mayo Clinic, Rochester, Minnesota

Canada

Kingston Health Sciences Center, Kingston, Ontario

University of Ottawa Heart Institute, Ottawa, Ontario

Key details

Phase

Large-scale testing

Sponsor

Ottawa Heart Institute Research Corporation

Enrollment target

~1,800 participants

Started

October 2018

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov